Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Madharry who wrote (8291)	5/7/2003 10:35:21 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 52153

<I just wonder if the drug companies believe it should be given under prescription and the FDA forces them to put it for sale OTC who will field product liability claims?> That's what courts are for - deciding issues. It seems to me that the companies can refuse to sell the drug OTC if they believe it requires MD supervision/scripting. If they sell it OTC they take with the benefits the risks of a suit. I do not believe for one second that companies would resist OTC status for a drug if they made more money by selling OTC. Everyone is driven by the almighty buck. The HMO's want OTC because it saves them money. Insured consumers want scripts since it is cheaper. Duh! There are many policy issues inherent in the FDA forcing drugs OTC. The disruption of a well understood economic model for drug development funding is at the top of my list followed closely by a disincentive for creating safe drugs. You get what you incent. (Formerly, you eat what you kill.) ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next